Correlation Between Adagene and INmune Bio
Can any of the company-specific risk be diversified away by investing in both Adagene and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and INmune Bio, you can compare the effects of market volatilities on Adagene and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and INmune Bio.
Diversification Opportunities for Adagene and INmune Bio
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Adagene and INmune is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Adagene i.e., Adagene and INmune Bio go up and down completely randomly.
Pair Corralation between Adagene and INmune Bio
Given the investment horizon of 90 days Adagene is expected to under-perform the INmune Bio. But the stock apears to be less risky and, when comparing its historical volatility, Adagene is 1.93 times less risky than INmune Bio. The stock trades about -0.1 of its potential returns per unit of risk. The INmune Bio is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 465.00 in INmune Bio on December 29, 2024 and sell it today you would earn a total of 287.00 from holding INmune Bio or generate 61.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Adagene vs. INmune Bio
Performance |
Timeline |
Adagene |
INmune Bio |
Adagene and INmune Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Adagene and INmune Bio
The main advantage of trading using opposite Adagene and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.Adagene vs. Aerovate Therapeutics | Adagene vs. Acrivon Therapeutics, Common | Adagene vs. Rezolute | Adagene vs. AN2 Therapeutics |
INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma | INmune Bio vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |